Adenoid cystic carcinoma is a rare malignant tumor that is well known for its deceptively encouraging 5-year survival rate and its dismal survival rate at longer intervals. Controversy exists as to the benefit of regularly following asymptomatic patients to look for distant metastases because even if one is found, the options for further management are limited. When a metastasis is limited to the lung in an asymptomatic patient with no locoregional recurrence, metastasectomy might provide some long-term benefit, although we cannot know for certain. We encountered such a case, and we opted for surgical resection rather than a conservative approach. There is a need for multicenter trials so that the management of such patients, be it active or conservative, can be evidence-based.
References
1.
BarnesL, EvesonJW, ReichartP, SidranskyD, eds. Pathology and Genetics: Head and Neck Tumours. KleihuesP, SobinLH, series eds. World Health Organization Classification of Tumours. Lyon, France: IARC Press; 2005.
2.
MoukarbelRV, GoldsteinDP, O'SullivanB, Adenoid cystic carcinoma of the larynx: A 40-year experience. Head Neck2008;30(7):919–24.
3.
HowardDJ, HaribhaktiW.Primary tumours of the trachea: Analysis of clinical features and treatment results. J Laryngol Otol1994;108(3):230–2.
4.
MarshWLJr., AllenMSJr.Adenoid cystic carcinoma: Biologic behavior in 38 patients. Cancer1979;43(4):1463–73.
5.
ConleyJ, DingmanDL. Adenoid cystic carcinoma in the head and neck (cylindroma). Arch Otolaryngol1974;100(2):81–90.
6.
RuschVW. Pulmonary metastasectomy. Current indications. Chest1995;107(6 Suppl):322S–331S.
PappoO, GezE.CraciunI, Growth rate analysis of lung metastases appearing 18 years after resection of cutaneous adenoid cystic carcinoma. Case report and review of the literature. Arch Pathol Lab Med1992;116(1):76–9.
9.
UmedaM, NishimatsuN, MasagoH, Tumor-doubling time and onset of pulmonary metastasis from adenoid cystic carcinoma of the salivary gland. Oral Surg Oral Med Oral Pathol Oral Radiol Endod1999;88(4):473–8.
10.
van de WalHJ, VerhagenA, LecluyseA, Surgery of pulmonary metastases. Thorac Cardiovasc Surg1986;34(Spec No 2):153–6.
11.
TakagiD, FukudaS, FurutaY, Clinical study of adenoid cystic carcinoma of the head and neck. Auris Nasus Larynx2001;28(Suppl):S99–S102.
12.
SpiroRH. Distant metastasis in adenoid cystic carcinoma of salivary origin. Am J Surg1997;174(5):495–8.
13.
HowardDJ, LundVJ. Reflections on the management of adenoid cystic carcinoma of the nasal cavity and paranasal sinuses. Otolaryngol Head Neck Surg1985;93(3):338–41.
14.
LiuD, LabowDM, DangN, Pulmonary metastasectomy for head and neck cancers. Ann Surg Oncol1999;6(6):572–8.
15.
RendinaEA, de VincentiisM, PrimeranoG, Pulmonary resection for metastatic laryngeal carcinoma. J Thorac Cardiovasc Surg1986;92(1):114–17.
16.
LocatiLD, GuzzoM, BossiP, Lung metastasectomy in adenoid cystic carcinoma (ACC) of salivary gland. Oral Oncol2005;41(9):890–4.
17.
BobbioA, CopelliC, AmpolliniL, Lung metastasis resection of adenoid cystic carcinoma of salivary glands. Eur J Cardiothorac Surg2008;33(5):790–3.
18.
PitmanMB, ShermanME, Black-SchafferWS. The use of fine-needle aspiration in the diagnosis of metastatic pulmonary adenoid cystic carcinoma. Otolaryngol Head Neck Surg1991;104(4):441–7.
BuddGT, GroppeCW. Adenoid cystic carcinoma of the salivary gland. Sustained complete response to chemotherapy. Cancer1983; 51(4):589–90.
21.
PeturssonSR. Adenoid cystic carcinoma of the esophagus. Complete response to combination chemotherapy. Cancer1986;57(8):1464–7.
22.
DreyfussAI, ClarkJR, FallonBG, Cyclophosphamide, doxorubicin, and cisplatin combination chemotherapy for advanced carcinomas of salivary gland origin. Cancer1987;60(12):2869–72.
23.
de HaanLD, de MulderPH, VermorkenJB, Cisplatin-based chemotherapy in advanced adenoid cystic carcinoma of the head and neck. Head Neck1992;14(4):273–7.
24.
VermorkenJB, VerweijJ, de MulderPH, Epirubicin in patients with advanced or recurrent adenoid cystic carcinoma of the head and neck: A phase II study of the EORTC Head and Neck Cancer Cooperative Group. Ann Oncol1993;4(9):785–8.
25.
VerweijJ, de MulderPH, de GraeffA, Phase II study on mitoxantrone in adenoid cystic carcinomas of the head and neck. EORTC Head and Neck Cancer Cooperative Group. Ann Oncol1996;7(8):867–9.
26.
van HerpenCM, LocatiLD, ButerJ, Phase II study on gemcitabine in recurrent and/or metastatic adenoid cystic carcinoma of the head and neck (EORTC 24982). Eur J Cancer2008;44(17):2542–5.
27.
HoistVA, MarshallCE, MoskalukCA, FriersonHFJr.KIT protein expression and analysis of c-kit gene mutation in adenoid cystic carcinoma. Mod Pathol1999;12(10):956–60.
28.
BruceIA, SlevinNJ, HomerJJ, Synergistic effects of imatinib (STI 571) in combination with chemotherapeutic drugs in head and neck cancer. Anticancer Drugs2005;16(7):719–26.
29.
AlcedoJC, FábregaJM, ArosemenaJR, UrrutiaA.Imatinib mesylateas treatment for adenoid cystic carcinoma of the salivary glands: Report of two successfully treated cases. Head Neck2004;26(9):829–31.
30.
HotteSJ, WinquistEW, LamontE, Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: A Princess Margaret Hospital phase II consortium study. J Clin Oncol2005;23(3):585–90.
31.
PfefferMR, TalmiY, CataneR, A phase II study of imatinib for advanced adenoid cystic carcinoma of head and neck salivary glands. Oral Oncol2007;43(1):33–6.
